Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 7(1): 11470, 2017 09 13.
Artigo em Inglês | MEDLINE | ID: mdl-28904402

RESUMO

In accordance with the classification of the International Agency for Research on Cancer, extremely low frequency magnetic fields (ELF-MF) are suspected to promote malignant progression by providing survival advantage to cancer cells through the activation of critical cytoprotective pathways. Among these, the major antioxidative and detoxification defence systems might be targeted by ELF-MF by conferring cells significant resistance against clinically-relevant cytotoxic agents. We investigated whether the hyperproliferation that is induced in SH-SY5Y human neuroblastoma cells by a 50 Hz, 1 mT ELF magnetic field was supported by improved defence towards reactive oxygen species (ROS) and xenobiotics, as well as by reduced vulnerability against both H2O2 and anti-tumor ROS-generating drug doxorubicin. ELF-MF induced a proliferative and survival advantage by activating key redox-responsive antioxidative and detoxification cytoprotective pathways that are associated with a more aggressive behavior of neuroblastoma cells. This was coupled with the upregulation of the major sirtuins, as well as with increased signaling activity of the erythroid 2-related nuclear transcription factor 2 (NRF2). Interestingly, we also showed that the exposure to 50 Hz MF as low as 100 µT may still be able to alter behavior and responses of cancer cells to clinically-relevant drugs.


Assuntos
Campos Magnéticos , Neuroblastoma/metabolismo , Neuroblastoma/patologia , Oxirredução , Biomarcadores , Linhagem Celular Tumoral , Doxorrubicina/metabolismo , Humanos , Peróxido de Hidrogênio/metabolismo , Inativação Metabólica , Fator 2 Relacionado a NF-E2/metabolismo , Gradação de Tumores , Neuroblastoma/etiologia , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Sirtuína 1/metabolismo , Sirtuína 3/metabolismo
2.
Oxid Med Cell Longev ; 2016: 3837623, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28116035

RESUMO

Population aging results in urgent needs of interventions aimed at ensuring healthy senescence. Exercise often results in healthy aging, yet many molecular mechanisms underlying such effects still need to be identified. We here investigated whether the age-dependent accumulation of oxidative and methylglyoxal- (MG-) related molecular damage could be delayed by moderate exercise in the mouse ovary, an organ that first exhibits impaired function with advancing age in mammals. CD1 female mice underwent two- or four-month treadmill-based running through the transition from adult to middle age, when ovaries show signs of senescence, and markers of protection against reactive oxygen species (ROS) and MG were measured. The long-term exercise reduced the protein oxidative damage in the ovaries (P < 0.01), and this was linked to the preservation of the glutathione peroxidase protection against ROS (P < 0.001), as well as to the increased glutathione availability (P < 0.001). Conversely, even though the age-related deactivation of the MG-targeting systems was partially prevented by the long-term running programme (P < 0.001), exercised mice were not protected from the age-dependent glycative burden. In summary, lately initiated regular and moderate exercise limited some changes occurring in the ovaries of middle-aged mice, and this might help to develop nonpharmacological cointerventions to reduce the vulnerability of mammalian ovaries towards redox dysfunctions.


Assuntos
Antioxidantes/metabolismo , Ovário/metabolismo , Envelhecimento , Animais , Catalase/metabolismo , Feminino , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Lactoilglutationa Liase/genética , Lactoilglutationa Liase/metabolismo , Camundongos , Ornitina/análogos & derivados , Ornitina/metabolismo , Ovário/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Condicionamento Físico Animal , Carbonilação Proteica/efeitos dos fármacos , Pirimidinas/metabolismo , Aldeído Pirúvico/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Reprodução/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Tioléster Hidrolases/genética , Tioléster Hidrolases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...